Cargando…

Management of neuropathic pain

Neuropathic pain is intractable pain caused by damage to the nervous system. Recent approval and expansion of the indications of a series of drugs are expected to improve the treatment strategies for neuropathic pain. Here, we present an outline of pain transmission pathways and relevant pharmacolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Noriko, Nomoto, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689392/
https://www.ncbi.nlm.nih.gov/pubmed/29263992
http://dx.doi.org/10.1002/jgf2.5
_version_ 1783279373881704448
author Nishikawa, Noriko
Nomoto, Masahiro
author_facet Nishikawa, Noriko
Nomoto, Masahiro
author_sort Nishikawa, Noriko
collection PubMed
description Neuropathic pain is intractable pain caused by damage to the nervous system. Recent approval and expansion of the indications of a series of drugs are expected to improve the treatment strategies for neuropathic pain. Here, we present an outline of pain transmission pathways and relevant pharmacological effects, along with points to consider in the use of neuropathic pain medications according to the guidelines of Japan Society of Pain Clinicians. The content of this article is almost similar to my other Japanese article that was published in the Journal of the Japanese Society of Internal Medicine. Although complete recovery from pain may be difficult, pharmacotherapy can relieve pain, thereby improving the patients’ quality of life.
format Online
Article
Text
id pubmed-5689392
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56893922017-12-20 Management of neuropathic pain Nishikawa, Noriko Nomoto, Masahiro J Gen Fam Med Review Articles Neuropathic pain is intractable pain caused by damage to the nervous system. Recent approval and expansion of the indications of a series of drugs are expected to improve the treatment strategies for neuropathic pain. Here, we present an outline of pain transmission pathways and relevant pharmacological effects, along with points to consider in the use of neuropathic pain medications according to the guidelines of Japan Society of Pain Clinicians. The content of this article is almost similar to my other Japanese article that was published in the Journal of the Japanese Society of Internal Medicine. Although complete recovery from pain may be difficult, pharmacotherapy can relieve pain, thereby improving the patients’ quality of life. John Wiley and Sons Inc. 2017-04-12 /pmc/articles/PMC5689392/ /pubmed/29263992 http://dx.doi.org/10.1002/jgf2.5 Text en © 2017 The Authors. Journal of General and Family Medicine published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Review Articles
Nishikawa, Noriko
Nomoto, Masahiro
Management of neuropathic pain
title Management of neuropathic pain
title_full Management of neuropathic pain
title_fullStr Management of neuropathic pain
title_full_unstemmed Management of neuropathic pain
title_short Management of neuropathic pain
title_sort management of neuropathic pain
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689392/
https://www.ncbi.nlm.nih.gov/pubmed/29263992
http://dx.doi.org/10.1002/jgf2.5
work_keys_str_mv AT nishikawanoriko managementofneuropathicpain
AT nomotomasahiro managementofneuropathicpain